SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

GH

Guardant Health Inc.
NASDAQHealth Care

Latest close: 158.60 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 16, 2026Notice of sale · Form 144Tariq Musa · Director · $19.2KOpen the filing ↗
  2. Oct 14, 2026Reported sale · Form 4Alex M Azar II · $11.0KOpen the filing ↗
  3. Oct 14, 2026Notice of sale · Form 144Azar Alex M II · Director · $11.0KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record1,18613 flagged findings
Reported transactions (Form 4)80since Aug 5, 2026 · and 16 other holdings
Corporate events (8-K)30since Jan 7, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

What the company does

Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers.

Source: Wikipedia (CC BY-SA 4.0) · copied on Sep 3, 2026 · may not reflect recent changes.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-05-07share offering or dilution eventrecentOpen filing ↗
    “…recorded as a reduction of the Company's stockholders’ equity on the condensed consolidated balance sheets. In November 2025, as…”
    +1 more passage from the same document
    • “…the Company reissued all of its treasury stock and recorded a gain of $ 42.9 million included in its additional paid-in capital on…”
  • 2026-05-07export control restrictionsrecentOpen filing ↗
    “…context of broader global, regional and U.S. economic and geopolitical conditions. For example, deterioration in the bilateral…”
  • 2026-05-07capital return (buybacks/dividends)recentOpen filing ↗
    “…the conversion rate applicable to the conversion of the 2027 Notes will be increased in certain circumstances if it is converted…”
    +1 more passage from the same document
    • “…the conversion of the 2027 Notes will be increased in certain circumstances if it is converted after it is called for redemption. If…”
  • 2026-05-07regulatory investigationrecentOpen filing ↗
    “…the United States District Court for the District of Delaware, seeking to show that Tempus’ allegations are without merit. On March…”

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 1,186)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

1,186 filings on record, the oldest from Oct 3, 18.

Listing the 25 most recent filings of the 1,186 on record.

8-Ks, explained

Structure17Governance26
  • Apr 27, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Nov 7, 25StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Sep 15, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Apr 9, 25StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Feb 14, 25StructureTook on a new financial obligation+3 more in the same filing8-K 2.03 ↗
  • Feb 7, 25StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Oct 24, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Aug 23, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Governance4 senior executive changes2024show all 4hide
    • Jul 18, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • May 31, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
    • Mar 22, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
    • Feb 1, 24GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Dec 21, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Nov 3, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • May 8, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗

9 older filings not shown · The record reaches back to Apr 23, 19.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • BlackRock, Inc.5.2%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
  • Vanguard Capital Management5.0%Mar 31, 26SCHEDULE 13G ↗
  • T. Rowe Price Associates, Inc.4.9%Jun 30, 26SCHEDULE 13G/A ↗1 earlier filing
  • Deep Track Capital, LP4.4%Mar 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Cadian Capital Management, LP4.2%Dec 31, 24SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
show one more holderhide
  • Wellington Management Group LLP3.9%Dec 31, 24SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Oct 16, Tariq Musa filed notice of intent to sell up to $19K. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

No sale of theirs is on record yet in Form 4; the 90-day window is still open.

View notice (Form 144) ↗+9 more recent notices · 9 with a later sale

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Oct 14, 26Sell$11KAlex M Azar II↗
Stock compensation, tax and giftsshow the 39 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Oct 12, 26Compensationamount n/aAlex M Azar II↗
  • Oct 1, 26Compensationamount n/aTerilyn J. MonroeChief People Officer↗
  • Oct 1, 26Compensationamount n/aTerilyn J. MonroeChief People Officer↗
  • Oct 1, 26Tax$367KTerilyn J. MonroeChief People Officer↗
  • Oct 1, 26Compensationamount n/aMichael Brian BellChief Financial Officer↗
  • Oct 1, 26Compensationamount n/aMichael Brian BellChief Financial Officer↗
  • Oct 1, 26Compensationamount n/aMichael Brian BellChief Financial Officer↗
  • Oct 1, 26Tax$684KMichael Brian BellChief Financial Officer↗
  • Oct 1, 26Compensationamount n/aJohn G. SaiaChief Legal Officer↗
  • Oct 1, 26Compensationamount n/aJohn G. SaiaChief Legal Officer↗
  • Oct 1, 26Compensationamount n/aJohn G. SaiaChief Legal Officer↗
  • Oct 1, 26Compensationamount n/aJohn G. SaiaChief Legal Officer↗
  • Oct 1, 26Tax$648KJohn G. SaiaChief Legal Officer↗
  • Oct 1, 26Compensationamount n/aHelmy EltoukhyCo-Chief Executive Officer↗
  • Oct 1, 26Compensationamount n/aHelmy EltoukhyCo-Chief Executive Officer↗
  • Oct 1, 26Tax$3.0MHelmy EltoukhyCo-Chief Executive Officer↗
  • Oct 1, 26Compensationamount n/aAmirAli TalasazCo-Chief Executive Officer↗
  • Oct 1, 26Compensationamount n/aAmirAli TalasazCo-Chief Executive Officer↗
  • Oct 1, 26Tax$3.0MAmirAli TalasazCo-Chief Executive Officer↗
  • Oct 1, 26Compensationamount n/aChris FreemanChief Commercial Officer↗
  • Oct 1, 26Compensationamount n/aChris FreemanChief Commercial Officer↗
  • Oct 1, 26Compensationamount n/aChris FreemanChief Commercial Officer↗
  • Oct 1, 26Compensationamount n/aChris FreemanChief Commercial Officer↗
  • Oct 1, 26Tax$549KChris FreemanChief Commercial Officer↗
  • Oct 1, 26Compensationamount n/aKumud KaliaChief Information Officer↗
  • Oct 1, 26Compensationamount n/aKumud KaliaChief Information Officer↗
  • Oct 1, 26Compensationamount n/aKumud KaliaChief Information Officer↗
  • Oct 1, 26Compensationamount n/aKumud KaliaChief Information Officer↗
  • Oct 1, 26Tax$536KKumud KaliaChief Information Officer↗
  • Oct 1, 26Compensationamount n/aDarya ChudovaChief Technology Officer↗
  • Oct 1, 26Compensationamount n/aDarya ChudovaChief Technology Officer↗
  • Oct 1, 26Compensationamount n/aDarya ChudovaChief Technology Officer↗
  • Oct 1, 26Compensationamount n/aDarya ChudovaChief Technology Officer↗
  • Oct 1, 26Tax$755KDarya ChudovaChief Technology Officer↗
  • Sep 30, 26Compensationamount n/aHelmy EltoukhyCo-Chief Executive Officer↗
  • Sep 30, 26Tax$255KHelmy EltoukhyCo-Chief Executive Officer↗
  • Sep 30, 26Compensationamount n/aAmirAli TalasazCo-Chief Executive Officer↗
  • Sep 30, 26Tax$255KAmirAli TalasazCo-Chief Executive Officer↗
  • Sep 21, 26Compensationamount n/aROBERTO MIGNONE↗

The full record holds 1,083 transactions and goes back to May 1, 22.

Its sector and its market

Guardant Health Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Guardant Health Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Guardant Health Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
1,186 documents on file, from Oct 3, 2018 to Oct 16, 2026.
Company description
Wikipedia, read on Sep 3, 2026.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.